Yu Xia
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Renal and related cancers 16
-
- Renal cell carcinoma treatment 29
- Ferroptosis and cancer prognosis 8
- Co-authors
- Jianming Guo (42 shared papers)Li Liu (41 shared papers)Qi Bai (41 shared papers)Jiejie Xu (36 shared papers)Ying Xiong (25 shared papers)Tianyu Zhong (4 shared papers)Yang Qu (21 shared papers)Lixia Jiang (4 shared papers)
- Journals
- OncoImmunology (7 papers)Oncotarget (6 papers)Cancer Immunology Immunotherapy (5 papers)Journal for ImmunoTherapy of Cancer (4 papers)Urologic Oncology Seminars and Original Investigations (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yu Xia
86 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 104
- Immunology 592
- Oncology 694
- Cancer Research 346
- Pulmonary and Respiratory Medicine 437
- Molecular Biology 650
Countries citing papers authored by Yu Xia
This map shows the geographic impact of Yu Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Xia more than expected).
Fields of papers citing papers by Yu Xia
This network shows the impact of papers produced by Yu Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Xia. The network helps show where Yu Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 139 | |
| 2 | 2022 | 97 | |
| 3 | 2015 | 95 | |
| 4 | 2018 | 75 | |
| 5 | 2020 | 67 | |
| 6 | 2018 | 48 | |
| 7 | 2022 | 46 | |
| 8 | 2020 | 40 | |
| 9 | 2019 | 40 | |
| 10 | 2016 | 38 | |
| 11 | 2020 | 38 | |
| 12 | 2018 | 38 | |
| 13 | 2019 | 36 | |
| 14 | 2020 | 36 | |
| 15 | 2020 | 36 | |
| 16 | 2020 | 33 | |
| 17 | 2013 | 32 | |
| 18 | 2020 | 29 | |
| 19 | 2018 | 27 | |
| 20 | 2020 | 26 |
About Yu Xia
Yu Xia is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Immunology and Cancer Research, having authored 89 papers that have together received 1.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (29 papers), Cancer Immunotherapy and Biomarkers (22 papers), Renal and related cancers (16 papers), Bladder and Urothelial Cancer Treatments (13 papers), Immune Cell Function and Interaction (12 papers), Ferroptosis and cancer prognosis (8 papers), MicroRNA in disease regulation (7 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Immunology (592 citations), Oncology (694 citations), Cancer Research (346 citations), Pulmonary and Respiratory Medicine (437 citations) and Molecular Biology (650 citations). Yu Xia has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jianming Guo, Li Liu, Qi Bai, Jiejie Xu, Ying Xiong, Tianyu Zhong, Yang Qu, Lixia Jiang, Jiajun Wang and Yu Zhu. Their work appears in journals such as OncoImmunology, Oncotarget, Cancer Immunology Immunotherapy, Journal for ImmunoTherapy of Cancer and Urologic Oncology Seminars and Original Investigations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.